REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ra-Pharm Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Basic Organic Chemical Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Real Estate | Real Estate Property Managers | Scientific Research and Development Services | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Ra-Pharm Sp. z o.o. Profile Updated: May 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Ra-Pharm Sp. z o.o. is based in Poland, with the head office in Krakow. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on November 12, 2020. Its’ total assets recorded a negative growth of 4.03%.

Headquarters
Ul. Zamknieta 10/1.5
Krakow; Malopolskie; Postal Code: 30-554

Contact Details: Purchase the Ra-Pharm Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ra-Pharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ra-Pharm Sp. z o.o. report to view the information.
Incorporation Date:
November 12, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Subsidiaries
Organic Pharma Sp. z o.o.
45%
Company Performance
Financial values in the chart are available after Ra-Pharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
110.92%▲
Operating profit (EBIT)
-35.63%▼
Net Profit (Loss) for the Period
-35.63%▼
Total assets
-4.03%▼
Total equity
-33.68%▼
Return on Equity (ROE)
0.36%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo